Rocket Pharmaceuticals Inc

NASDAQ:RCKT   3:59:59 PM EDT
34.19
+0.52 (+1.54%)
Products

Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold On Danon Disease Trial Of Rp-A501

Published: 08/16/2021 11:29 GMT
Rocket Pharmaceuticals Inc (RCKT) - Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of Rp-a501.
Rocket Pharmaceuticals Inc - Initiation of Pediatric Patient Dosing of Rp-a501 Expected in Q3.
Rocket Pharmaceuticals Inc - Comprehensive Clinical Update From Phase 1 Clinical Trial Planned for Q4.
Rocket Pharmaceuticals - No New Drug-related Safety Events Were Observed in Low/higher-dose Young Adult Cohorts As Part of Clinical Hold Or During.